THE SPECIFICITY AND RELEVANCE OF THE USE OF IN VITRO METHODS IN THE DIAGNOSIS OF BACTERIOLOGICAL DISEASES
Article Sidebar
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Main Article Content
Аннотация:
Bacterial infections significantly affect morbidity and mortality connected to public health. Bacterial infections continue to be a huge global economic and social burden despite great advancements in their prevention and treatment. ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species) is a list of six very pathogenic, multidrug-resistant bacteria that cause potentially fatal illnesses. The most common causes of nosocomial infections include Clostridium difficile, Escherichia coli, Campylobacter spp. (C. jejuni and C. coli), Legionella spp., Salmonella spp. and Neisseria gonorrhoeae. The early commencement of effective antibiotic therapy, the resolution of outbreaks, and the reduction of subsequent antimicrobial resistance all depend on the prompt and precise diagnosis of these bacteria.
Article Details
Как цитировать:
Библиографические ссылки:
Gerace E, Mancuso G, Midiri A, Poidomani S, Zummo S, Biondo C. Recent Advances in the Use of Molecular Methods for the Diagnosis of Bacterial Infections. Pathogens. 2022 Jun 8;11(6):663. doi: 10.3390/pathogens11060663.
Abras, A., Ballart, C., Llovet, T., Roig, C., Gutiérrez, C., Tebar, S., et al. (2018). Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: a comparative study of sample treatments, DNA extraction methods and real-time PCR assays. PLoS One 13:738. doi: 10.1371/journal.pone.0195738
American Red Cross. Infectious Disease, HLA and ABO Donor Qualification Testing. (2024). Available at: https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html.
Andrade, M. V., Noronha, K. V. M. S., Souza, A., Motta-Santos, A. S., Braga, P. E. F., Bracarense, H., et al. (2023). The economic burden of Chagas disease: a systematic review. PLOS Neglect Trop Dis 17:e0011757. doi: 10.1371/journal.pntd.0011757
Barnabé, C., Brenière, S. F., Santillán-Guayasamín, S., Douzery, E. J. P., and Waleckx, E. (2023). Revisiting gene typing and phylogeny of Trypanosoma cruzi reference strains: comparison of the relevance of mitochondrial DNA, single-copy nuclear DNA, and the intergenic region of mini-exon gene. Infect. Genet. Evol. 115:105504. doi: 10.1016/j.meegid.2023.105504
Benatar, A. F., Danesi, E., Besuschio, S. A., Bortolotti, S., Cafferata, M. L., Ramirez, J. C., et al. (2021). Prospective multicenter evaluation of real time PCR kit prototype for early diagnosis of congenital Chagas disease. EBioMedicine 69:103450. doi: 10.1016/j.ebiom.2021.103450
Bern, C., Messenger, L. A., Whitman, J. D., and Maguire, J. H. (2020). Chagas disease in the United States: a public health approach. Clin. Microbiol. Rev. 33:19. doi: 10.1128/CMR.00023-19
Besuschio, S. A., Picado, A., Muñoz-Calderón, A., Wehrendt, D. P., Fernández, M., Benatarid, A., et al. (2020). Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi loopamp) kit for detection of congenital, acute and chagas disease reactivation. PLoS Negl. Trop. Dis. 14:e0008402. doi: 10.1371/journal.pntd.0008402
Bisio, M. M. C., Rivero, R., Gonzalez, N., Ballering, G., D’Amico, I., Kessler, C., et al. (2021). Diagnostic accuracy of two molecular tools for diagnosis of congenital Chagas disease. Mol. Diagn. Ther. 25, 791–801. doi: 10.1007/s40291-021-00553-3
Brossas, J. Y., Griselda, B., Bisio, M., Guihenneuc, J., Gulin, J. E. N., Jauréguiberry, S., et al. (2021). Evaluation of the chagas western blot igg assay for the diagnosis of chagas disease. Pathogens 10. doi: 10.3390/pathogens10111455
Candia-Puma, M. A., Machaca-Luque, L. Y., Roque-Pumahuanca, B. M., Galdino, A. S., Giunchetti, R. C., et al. (2022). Accuracy of diagnostic tests for the detection of Chagas disease: a systematic review and Meta-analysis. Diagnostics 12:2752. doi: 10.3390/diagnostics12112752
Castro-Sesquen, Y. E., Saldaña, A., Patino Nava, D., Bayangos, T., Paulette Evans, D., DeToy, K., et al. (2021a). Use of a latent class analysis in the diagnosis of chronic Chagas disease in the Washington metropolitan area. Clin. Infect. Dis. 72, e303–e310. doi: 10.1093/cid/ciaa1101
Centers for Disease Control and Prevention (2021). American Trypanosomiasis. Available at: https://www.cdc.gov/dpdx/trypanosomiasisamerican/index.html.
Daltro, R. T., Santos, E. F., Silva, Â. A. O., Maron Freitas, N. E., Leony, L. M., Vasconcelos, L. C. M., et al. (2022). Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: a proof-of-concept study. PLoS Negl. Trop. Dis. 16:e0010944. doi: 10.1371/journal.pntd.0010944
de Oliveira, L. C., Pereira, N. B., Moreira, C. H. V., Bierrenbach, A. L., Salles, F. C., de Souza-Basqueira, M., et al. (2020). ELISA saliva for Trypanosoma cruzi antibody detection: an alternative for serological surveys in endemic regions. Am. J. Trop. Med. Hyg. 102, 800–803. doi: 10.4269/ajtmh.18-0330
Ferreira-Silva, M. M., Pereira, G. A., Rodrigues-Júnior, V., Meira, W. S., Basques, F. V., Langhi-Júnior, D. M., et al. (2021). Chagas disease: performance analysis of immunodiagnostic tests anti-Trypanosoma cruzi in blood donors with inconclusive screening results. Therapy 43, 410–416. doi: 10.1016/j.htct.2020.06.016
Flores-Chavez, M. D., Abras, A., Ballart, C., Perez, I. I., Perez-Gordillo, P., Gállego, M., et al. (2021). Evaluation of the performance of the loopamp trypanosoma cruzi detection kit for the diagnosis of chagas disease in an area where it is not endemic, Spain. J. Clin. Microbiol. 59:20. doi: 10.1128/JCM.01860-20
Forsyth, C. J., Manne-Goehler, J., Bern, C., Whitman, J., Hochberg, N. S., Edwards, M., et al. (2022). Recommendations for screening and diagnosis of Chagas disease in the United States. J Infect Dis 225, 1601–1610. doi: 10.1093/infdis/jiab513
Gállego, M., Schijman, A. G., and Alonso-Padilla, J. (2020). “Diagnosis of Trypanosoma cruzi infection: Challenges on laboratory tests development and applications,” in Chagas disease. eds. M. J. Pinazo Delgado and J. Gascón (Cham: Springer).
Moser, M. S., Fleischmann, C. J., Kelly, E. A., Prince, H. E., Bern, C., and Whitman, J. D. (2023b). Concordance of results by three Chagas disease antibody assays in U.S. clinical specimens. J. Clin. Microbiol. 61:e0181422. doi: 10.1128/jcm.01814-22
Rentschler S, Kaiser L, Deigner H-P. Emerging Options for the Diagnosis of Bacterial Infections and the Characterization of Antimicrobial Resistance. International Journal of Molecular Sciences. 2021; 22(1):456. https://doi.org/10.3390/ijms22010456